We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Toyota
TM
$221B
| $4.01M | 0.03% |
32,359
+32,029
| +9,706% | +$3.91M |
|
552
Unifirst Corp
UNF
$5.43B
| $4M | 0.03% |
21,225
-7,412
| -26% | -$1.2M |
|
553
OceanFirst Financial
OCFC
$1.74B
| $3.99M | 0.03% |
160,513
+131,954
| +462% | +$3.24M |
|
|
CIT
554
DELISTED
CIT Group Inc.
CIT
| $3.98M | 0.03% |
75,844
-128,050
| -63% | -$6.48M |
|
555
Enterprise Financial Services Corp
EFSC
$2.44B
| $3.98M | 0.03% |
95,673
-15,041
| -14% | -$629K |
|
|
RAVN
556
DELISTED
Raven Industries Inc
RAVN
| $3.97M | 0.03% |
110,749
-33,475
| -23% | -$1.23M |
|
557
State Street
STT
$50.2B
| $3.97M | 0.03% |
70,798
-143,220
| -67% | -$8.9M |
|
558
Tenaris
TS
$28.1B
| $3.96M | 0.03% |
150,642
-600,623
| -80% | -$16.1M |
|
559
Columbus McKinnon
CMCO
$467M
| $3.95M | 0.03% |
94,156
-75,537
| -45% | -$2.87M |
|
560
Kosmos Energy
KOS
$1.39B
| $3.94M | 0.03% |
629,205
+305,056
| +94% | +$1.95M |
|
561
Enova International
ENVA
$6.2B
| $3.94M | 0.03% |
+171,117
| New | +$4.1M |
|
562
Tenet Healthcare
THC
$22.6B
| $3.94M | 0.03% |
190,583
-7,359
| -4% | -$170K |
|
563
Broadridge
BR
$18.3B
| $3.92M | 0.03% |
30,732
+19,176
| +166% | +$2.31M |
|
564
Cigna
CI
$79.6B
| $3.9M | 0.03% |
+24,770
| New | +$3.88M |
|
|
BBL
565
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $3.89M | 0.03% |
76,098
-4,690
| -6% | -$224K |
|
566
Commault Systems
CVLT
$4.97B
| $3.88M | 0.03% |
78,218
-161,579
| -67% | -$8.59M |
|
567
LeMaitre Vascular
LMAT
$2.34B
| $3.81M | 0.03% |
136,344
-24,431
| -15% | -$679K |
|
|
LEXEA
568
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $3.8M | 0.03% |
79,510
-43,855
| -36% | -$1.94M |
|
|
FMBI
569
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $3.79M | 0.03% |
+185,114
| New | +$3.83M |
|
570
Grupo Aeroportuario del Sureste
ASR
$8.14B
| $3.78M | 0.03% |
23,338
+1,279
| +6% | +$209K |
|
|
HTBK
571
DELISTED
Heritage Commerce
HTBK
| $3.78M | 0.03% |
308,456
+133,398
| +76% | +$1.64M |
|
|
BPMP
572
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $3.77M | 0.03% |
243,250
+162,567
| +201% | +$2.41M |
|
|
EPAY
573
DELISTED
Bottomline Technologies Inc
EPAY
| $3.76M | 0.03% |
84,988
+84,085
| +9,312% | +$3.9M |
|
574
Boeing
BA
$175B
| $3.75M | 0.03% |
10,300
-27,362
| -73% | -$9.98M |
|
575
Heartland Express
HTLD
$1.04B
| $3.75M | 0.03% |
+207,426
| New | +$3.96M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.